Clarke A Low, MD

Clarke A Low, MD

Oncology

Intermountain Medical Group Member
Offers Video Visits
Accepting New Patients
Patient Satisfaction

()

Patient Satisfaction

No ratings yet? Why?

Office Location

Main Office
Accepting new patients
SelectHealth Plans
  • CHIP
  • SelectHealth Care
  • SelectHealth Choice
  • SelectHealth Community Care
  • SelectHealth Med
  • SelectHealth Medicare
  • SelectHealth Share
  • SelectHealth Signature
  • SelectHealth Value

Note: This list only shows the SelectHealth plans accepted by the provider. Contact the provider's office to learn what other insurance plans are accepted.

More

Professional Summary

Degree

  • Baylor College of Medicine - Houston, TX in Doctor of Medicine, 2008 - 2012
Training
  • Residency: UCLA Medical Center - Los Angeles, CA in Internal Medicine, 2012 - 2015
  • Fellowship: Huntsman Cancer Institute - Salt Lake City, UT in Hematology/Oncology, 2015 - 2018
Board Certifications
  • AM BD INTERNAL MEDICINE - Certification does not expire
  • AM BD INTERNAL MEDICINE (HEMATOLOGY) - Certification does not expire
  • AM BD INTERNAL MEDICINE (MEDICAL ONCOLOGY) - Certification does not expire
Professional Memberships
  • American Society of Clinical Oncology
  • Utah Medical Association
Languages Spoken
  • English

Practice Focus

I specialize in treating cancers of the lung, thymus, thyroid, and head and neck area. I have experience in treating these cancers with all types of systemic therapy including chemotherapy, targeted therapy, and immunotherapy. I also collaborate with surgeons, radiation, oncologists and other health care providers to provide an optimal, multidisciplinary treatment plan for cancer patients.

Verified Patient Ratings

The Patient Rating score is an average of all responses to physician related questions on the nationally developed CAHPS Clinician & Group Survey (CG-CAHPS). Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about the survey

Verified Patient Comments

Comments also are gathered from the CG-CAHPS survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.